Dr. Ralph W Dickson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 Academy St, Mc Sherrystown, PA 17344 Phone: 717-637-4188 Fax: 717-637-7803 |
Dr. Russell Carlisle Hess, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 70 Academy St, Mc Sherrystown, PA 17344 Phone: 717-637-4188 Fax: 717-637-7803 |
News Archive
Biovista Inc. today announced that BVA-201, its drug targeting Multiple Sclerosis (MS), has shown significant positive results in the MOG-induced Experimental Allergic Encephalomyelitis (EAE) murine model of MS. BVA-201 is an existing drug that Biovista repositioned in MS and is aimed at neuroprotection. It was shown to have both efficacy in reducing symptoms and no toxic effects in this well established model of MS.
An influential article in the journal Progress in Neurobiology provided one of the first comprehensive reviews of how estrogen potentially can protect against Alzheimer's disease and other neurological disorders.
Exhaust fumes heighten the risk of asthma in children who are already genetically susceptible to respiratory disease, indicates research published ahead of print in the journal Thorax.
The Alzheimer's vaccine known as Affitope AD01 from Affiris has now entered the clinical phase of its development. All relevant regulatory and statutory approvals have been secured and this innovative treatment is now being tested on humans for the first time.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
› Verified 1 days ago